Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
Financial Results:
Torrent Pharmaceuticals Ltd reported Revenues for Q4FY25 of ₹2,959.00 Crores up from ₹2,745.00 Crore year on year, a rise of 7.8%.
Total Expenses for Q4FY25 of ₹2,252.00 Crores up from ₹2,145.00 Crores year on year, a rise of 4.99%.
Consolidated Net Profit of ₹498.00 Crores up 10.91% from ₹449.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹14.71, up 10.85% from ₹13.27 in the same quarter of the previous year.
![](data:image/svg+xml;charset=utf-8,<svg height="781px" width="640px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
